HAPV3.SA · bank / insurer · relative-multiples view
Hapvida Participações e Investimentos S.A. (HAPV3.SA): Valuation Snapshot
Hapvida Participações e Investimentos S.A. (HAPV3.SA) is a bank, insurer or other financial, and a discounted-cash-flow model is the wrong lens for one, so TickerWorth does not publish a DCF fair value for it. What its filings and market data do show is below. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
How is a bank like HAPV3.SA valued?
This is a bank / insurer / financial. A free-cash-flow DCF is structurally the wrong lens here (their debt and float are raw material, not financing), so we don't publish one. Our bank model (justified price-to-book) declined to value it too: our cost-of-equity inputs are US-market (10-year Treasury, US equity risk premium); we don't apply them to a BRL listing. The price-to-book and price-to-earnings figures below are context for comparison, not a fair value.
Bank model (justified price-to-book)
Not published. Our cost-of-equity inputs are US-market (10-year Treasury, US equity risk premium); we don't apply them to a BRL listing.
What is HAPV3.SA's TickerWorth Score?
Cheap against our estimate — but a weaker business
Compared with Financial Services companies in Latin America
Its strongest point: trades below our estimate of what it's worth. Its weakest: profitability is weak.
- Value · 71 of 100
Cheaper than 71% of Financial Services companies worldwide
- Price vs worth · 99 of 100
- Quality · 17 of 100
More profitable than 17% of Financial Services companies worldwide
- Financial health · 43 of 100
Financially stronger than 43% of Financial Services companies worldwide
- Growth · 91 of 100
Growing faster than 91% of Financial Services companies worldwide
- Momentum · 20 of 100
Outperformed 20% of Financial Services companies worldwide over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- 8.81
- Market cap
- 4,
185, 524, 992 - 52-week high
- 33.51
- 52-week low
- 6.01
- Currency
- BRL
- Exchange
- São Paulo
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
Hapvida Participações e Investimentos S.A. (HAPV3.SA) is a bank, insurer or other financial, and a free-cash-flow discounted-cash-flow (DCF) model is structurally the wrong lens for it: for these businesses debt and float are raw material, not financing, so there is no meaningful 'free cash flow' to discount. Instead of a misleading intrinsic-value number, this page reads HAPV3.SA the way financials are actually valued — on relative multiples such as price-to-earnings and, above all, price-to-book — plus a plain description of where the stock trades. It is a descriptive snapshot, not a valuation, and not investment advice.
Read the full reasoning
On the numbers we do have, HAPV3.SA trades at a recent price of 8.81, a market capitalisation of about 4,185,524,992, sitting 10% of the way up its 52-week range (6.01–33.51), on the São Paulo.
The standard alternative to a DCF is relative valuation — comparing HAPV3.SA's trading multiples against a sector benchmark. Here that gives Fwd P/E of 8.2× (cheaper than the peer median of 13.3×); P/B of 0.1× (cheaper than the peer median of 2.6×); P/S of 0.1× (cheaper than the peer median of 4.7×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. HAPV3.SA shows a price-to-book (P/B) of 0.09 and book value of 101.17 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.
Finally, a price-based read — explicitly not a valuation. HAPV3.SA is in a mixed trend, trading -73.7% from its 52-week high. Over the past year the stock is -74.9%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
To be exact about what this page is not: we are not saying the numbers for HAPV3.SA are unavailable. They are, and they are above. We are saying a discounted-cash-flow model is the wrong instrument for this kind of business, and publishing one anyway — because the inputs happen to exist — would be a precise answer to the wrong question. Refusing is the more useful answer, and it is the same rule we apply to every name in this category.
HAPV3.SA vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | HAPV3.SA | Peer median | Read |
|---|---|---|---|
| Fwd P/E | 8.2× | 13.3× | cheaper than |
| P/B | 0.1× | 2.6× | cheaper than |
| P/S | 0.1× | 4.7× | cheaper than |
What does Hapvida Participações e Investimentos S.A. do?
What does it do?
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. It operates in the Insurance - Life industry (Financial Services sector), headquartered in Brazil.
How does it make money?
The business turns 31.9B in annual revenue into profit. Out of every $100 of sales, about $39 is left as operating profit (operating margin of 38.6%), after a 13% gross margin on the products/services it sells. After all costs, taxes and interest, -0.5% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries modest debt (0.3× equity), comfortably covers its short-term bills (1.8× current ratio), and is currently lossmaking.
HAPV3.SA insider trading
Insider filings are available for US-listed companies only.
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.